These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 15016009)

  • 1. A role of late Epstein-Barr virus infection in multiple sclerosis.
    Haahr S; Plesner AM; Vestergaard BF; Höllsberg P
    Acta Neurol Scand; 2004 Apr; 109(4):270-5. PubMed ID: 15016009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus and multiple sclerosis.
    Ascherio A; Munch M
    Epidemiology; 2000 Mar; 11(2):220-4. PubMed ID: 11021623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus and multiple sclerosis.
    Pohl D
    J Neurol Sci; 2009 Nov; 286(1-2):62-4. PubMed ID: 19361810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus in pediatric multiple sclerosis.
    Alotaibi S; Kennedy J; Tellier R; Stephens D; Banwell B
    JAMA; 2004 Apr; 291(15):1875-9. PubMed ID: 15100207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
    Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ
    JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus cause of multiple sclerosis.
    Tselis A
    Curr Opin Rheumatol; 2012 Jul; 24(4):424-8. PubMed ID: 22617821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
    Jilek S; Schluep M; Meylan P; Vingerhoets F; Guignard L; Monney A; Kleeberg J; Le Goff G; Pantaleo G; Du Pasquier RA
    Brain; 2008 Jul; 131(Pt 7):1712-21. PubMed ID: 18550621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom.
    Kuri A; Jacobs BM; Vickaryous N; Pakpoor J; Middeldorp J; Giovannoni G; Dobson R
    BMC Public Health; 2020 Jun; 20(1):912. PubMed ID: 32532296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Epstein-Barr virus-specific antibodies in Cypriot multiple sclerosis patients.
    Deeba E; Koptides D; Gaglia E; Constantinou A; Lambrianides A; Pantzaris M; Krashias G; Christodoulou C
    Mol Immunol; 2019 Jan; 105():270-275. PubMed ID: 30562647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma viral load of Epstein-Barr virus and risk of multiple sclerosis.
    Wagner HJ; Munger KL; Ascherio A
    Eur J Neurol; 2004 Dec; 11(12):833-4. PubMed ID: 15667414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Epstein-Barr virus and multiple sclerosis: epidemiological evidence.
    Ascherio A; Munger KL
    Clin Exp Immunol; 2010 Apr; 160(1):120-4. PubMed ID: 20415861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered prevalence and reactivity of anti-Epstein-Barr virus antibodies in patients with multiple sclerosis.
    Wagner HJ; Hennig H; Jabs WJ; Siekhaus A; Wessel K; Wandinger KP
    Viral Immunol; 2000; 13(4):497-502. PubMed ID: 11192296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic Response to the Epstein-Barr Virus Peptidome and the Risk for Multiple Sclerosis.
    Cortese M; Leng Y; Bjornevik K; Mitchell M; Healy BC; Mina MJ; Mancuso JD; Niebuhr DW; Munger KL; Elledge SJ; Ascherio A
    JAMA Neurol; 2024 May; 81(5):515-524. PubMed ID: 38497939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
    Otto C; Hofmann J; Ruprecht K
    Med Hypotheses; 2016 Jun; 91():109-113. PubMed ID: 27142157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to infant siblings during early life and risk of multiple sclerosis.
    Ponsonby AL; van der Mei I; Dwyer T; Blizzard L; Taylor B; Kemp A; Simmons R; Kilpatrick T
    JAMA; 2005 Jan; 293(4):463-9. PubMed ID: 15671431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr Virus Infection in Multiple Sclerosis Patients.
    Awwad AM; Hanafi NF; Achmawi GA; Naguib AM
    Egypt J Immunol; 2017 Jan; 24(1):49-55. PubMed ID: 29120577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of reactive Epstein-Barr Virus (EBV) in Iranian patient with different subtypes of multiple sclerosis (MS).
    Ramroodi N; Niazi AA; Sanadgol N; Ganjali Z; Sarabandi V
    Braz J Infect Dis; 2013; 17(2):156-63. PubMed ID: 23465600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein-Barr Virus in MS Development: A Presymptomatic Case-Control Study.
    Grut V; Biström M; Salzer J; Stridh P; Jons D; Gustafsson R; Huang J; Bergström T; Kockum I; Waterboer T; Olsson T; Sundström P
    Ann Neurol; 2024 Aug; 96(2):302-305. PubMed ID: 38860471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus reactivation and multiple sclerosis.
    Torkildsen Ø; Nyland H; Myrmel H; Myhr KM
    Eur J Neurol; 2008 Jan; 15(1):106-8. PubMed ID: 18042233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Epstein-Barr virus seroconversion and immunohistochemical changes in tonsils of pediatric solid organ transplant recipients.
    Shapiro NL; Tang CG; Bhattacharyya N
    Laryngoscope; 2011 Aug; 121(8):1718-25. PubMed ID: 21792960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.